BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11550160)

  • 21. Expression of p53 and proliferation index as prognostic factors in gastrointestinal sarcomas.
    Medina-Franco H; Ramos-De la Medina A; Cortes-Gonzalez R; Baquera J; Angeles-Angeles A; Urist MM; Eltoum IE; Heslin MJ
    Ann Surg Oncol; 2003 Mar; 10(2):190-5. PubMed ID: 12620916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
    Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
    Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas.
    Masciullo V; Berardengo E; Boglione A; Sgambato A; Bernardi A; Forni M; Linari A; Cito L; Scambia G; Comandone A; Giordano A
    Clin Cancer Res; 2008 Aug; 14(15):4775-9. PubMed ID: 18676747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of CD100 expression in soft tissue sarcoma.
    Ch'ng E; Tomita Y; Zhang B; He J; Hoshida Y; Qiu Y; Morii E; Nakamichi I; Hamada K; Ueda T; Aozasa K
    Cancer; 2007 Jul; 110(1):164-72. PubMed ID: 17520683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.
    Rudolph P; Kellner U; Chassevent A; Collin F; Bonichon F; Parwaresch R; Coindre JM
    Am J Pathol; 1997 Jun; 150(6):1997-2007. PubMed ID: 9176393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.
    Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
    World J Surg Oncol; 2016 Feb; 14(1):43. PubMed ID: 26911364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
    Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness.
    Huuhtanen RL; Blomqvist CP; Böhling TO; Wiklund TA; Tukiainen EJ; Virolainen M; Tribukait B; Andersson LC
    Cancer Res; 1999 Jun; 59(12):2885-90. PubMed ID: 10383150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors.
    Dhall D; Mertens R; Bresee C; Parakh R; Wang HL; Li M; Dhall G; Colquhoun SD; Ines D; Chung F; Yu R; Nissen NN; Wolin E
    Hum Pathol; 2012 Apr; 43(4):489-95. PubMed ID: 21937080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative immunohistochemical evaluation of MIB-1 labeling index in adult soft-tissue sarcomas by computer-assisted image analysis.
    Hasegawa T; Yamamoto S; Matsuno Y
    Pathol Int; 2002 Jul; 52(7):433-7. PubMed ID: 12167100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
    Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D
    Cancer; 2002 Aug; 95(3):634-40. PubMed ID: 12209757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardizing evaluation of sarcoma proliferation- higher Ki-67 expression in the tumor periphery than the center.
    Fernebro J; Engellau J; Persson A; Rydholm A; Nilbert M
    APMIS; 2007 Jun; 115(6):707-12. PubMed ID: 17550378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.
    Salerno G; Di Vizio D; Staibano S; Mottola G; Quaremba G; Mascolo M; Galli V; De Rosa G; Insabato L
    BMC Cancer; 2006 Jun; 6():146. PubMed ID: 16740156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
    Takahiro T; Shinichi K; Toshimitsu S
    Clin Cancer Res; 2003 Jun; 9(6):2204-12. PubMed ID: 12796387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
    Kang S; Han I; Lee S; Kim W; Kim H
    Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.
    Seinen JM; Jönsson M; Bendahl PO; Baldetorp B; Rambech E; Åkerman M; Rydholm A; Nilbert M; Carneiro A
    Hum Pathol; 2012 Dec; 43(12):2247-54. PubMed ID: 22789784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
    Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S
    Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
    Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
    Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.